Business Context and Reporting Period
Company: HealthEquity, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 23, 2024
Principal Executive Offices: Draper, Utah
Reporting Period: This filing reports on events occurring on August 23, 2024, specifically regarding the restructuring of the company's credit facilities.
Key Financial Metrics and Debt Structure
This filing focuses on debt refinancing rather than operational financial performance (revenue, profit, or cash flow). The filing text does not provide current revenue, profit, or operating cash flow figures.
- Debt Repaid: $511.9 million (outstanding obligations under the Prior Credit Agreement dated October 8, 2021).
- New Facility Size: Up to $1,000,000,000 aggregate principal amount (five-year senior secured revolving credit facility).
- Initial Borrowing: $511.9 million borrowed under the new facility to refinance the prior debt.
- Letters of Credit Sub-limit: $25,000,000.
- Expansion Capacity: Potential to incur additional loans up to $450,000,000 plus an accordion feature, subject to a pro forma first lien net leverage ratio not exceeding 3.85 to 1.00.
- Interest Rate Structure: Term SOFR (plus 0.10% credit spread adjustment) plus a margin of 1.25% to 2.50%, or an alternate base rate plus a margin of 0.25% to 1.50%.
- Commitment Fees: Quarterly fee on unused amounts ranging from 0.25% to 0.50%.
Material Changes Versus Prior Period
The primary material change is the termination of the Prior Credit Agreement and the entry into a new Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent.
- Facility Termination: The Prior Credit Agreement (revolving and term loan facilities) was fully repaid and terminated.
- Facility Expansion: The new facility increases the maximum available credit capacity from the prior arrangement to $1.0 billion, with potential expansion capabilities.
- Covenant Structure: The new agreement introduces specific financial performance covenants effective beginning with the fiscal quarter ending January 31, 2025.
Guidance, Outlook, Risks, and Covenants
Management Commentary and Usage: The new Revolving Credit Facility is intended for working capital, general corporate purposes, financing acquisitions, and other investments.
Financial Covenants (Effective Q1 2025):
- Maximum Total Net Leverage Ratio: No greater than 5.00 to 1.00.
- Minimum Consolidated Interest Coverage Ratio: No less than 3.00 to 1.00.
Risks and Contingencies:
- Events of Default: Include failure to pay principal/interest, material inaccuracy of representations, covenant violations, cross-defaults, material judgments, change of control, and insolvency events.
- Acceleration: Repayment obligations may be accelerated upon an event of default.
- Security: Obligations are unconditionally guaranteed by domestic subsidiaries and secured by substantially all assets of the Company and guarantors.
- Restrictions: The agreement limits the ability to incur additional indebtedness, create liens, merge, make investments, dispose of assets, and pay dividends, subject to customary exceptions.
Investor Verification Checklist
- Verify the exact terms of the leverage-based pricing grid to understand potential interest rate fluctuations.
- Confirm the company's current leverage ratio to assess proximity to the new 5.00 to 1.00 covenant threshold effective January 31, 2025.
- Review the full text of the Credit Agreement (Exhibit 10.1) for specific definitions of "Total Net Leverage Ratio" and "Consolidated Interest Coverage Ratio."
- Monitor future filings for any utilization of the accordion feature to increase the facility beyond $1.0 billion.
- Assess the impact of the new covenants on the company's ability to pursue acquisitions or make distributions.